PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
04-Oct-2023 CTMC partners with ScaleReady to automate, close, and scale for greater patient accessibility ScaleReady
04-Oct-2023 PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation PureTech Health plc
04-Oct-2023 Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO Myricx
04-Oct-2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Rejuvenate Biomed NV
04-Oct-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
04-Oct-2023 Velocity opens three UK greenfield clinical research sites Velocity
04-Oct-2023 Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program Janssen
03-Oct-2023 Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease Cassava Sciences
03-Oct-2023 Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System Amber Implants
03-Oct-2023 Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN) Novartis
29-Sep-2023 Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences EmendoBio
29-Sep-2023 Eplontersen Phase III results published in JAMA showing consistent and sustained benefit at 35, 66 and 85-week analyses AstraZeneca
28-Sep-2023 Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment Quotient Sciences
26-Sep-2023 XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke XBiotech Inc.
26-Sep-2023 4SC: Landmark RESMAIN study data presented at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 4SC AG
26-Sep-2023 Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial DopaVision
25-Sep-2023 palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications Veeva Systems
25-Sep-2023 Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial AstraZeneca
22-Sep-2023 Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations Veranova
22-Sep-2023 Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial AstraZeneca